Glenmark Pharmaceuticals S.a.

Glenmark Pharmaceuticals Limited

Usv Private Limited

Glenmark Life Sciences Limited

Sachin Baban Gavhane

Suresh Mahadev Kadam

Sandeep Bandu Khandagale

Shekhar Bhaskar Bhirud

Laxmikant Atmaram Gharat

Nagarajan Muthukaman

Sunil P Nirgude

Shailesh Shrirang Pawase

Rajesh Kumar Dwivedi

Abraham Thomas

Sukeerthi Kumar

Sukumar Sinha

Venkatasubramanian Radhakrishnan Tarur

Bipin Parsottam Kansagra

Jayant Prakashrao Patil

Shailendra Nilkanth Bhadane

Bhavna Mishra

Anil Purushottam Joshi

Sunil Pandurang Nirgude

Ajit Shankar Mindhe

Aniket Ashokrao Deshpande

Anil Subhash Bhujbal

Rajesh Dwivedi

Shailendra Bhadane

Shailesh Pawase

The present invention relates to a process for preparation of apremilast. The present invention relates to p-xylene solvate of apremilast and process for its preparation.

Process for the preparation of apremilast

The present application relates to solid state forms of a triazolone compound which exhibit mPGES-1 enzyme inhibition activity, specifically N-(4-chloro-3-(5-oxo-1-(4-(trifluoromethyl)phenyl)-4,5-dihydro-1H-1,2,4-triazol-3-yl)benzyl)pivalamide (Compound of formula II), and process for preparation thereof. 

Polymorphs of a mPGES-1 inhibiting triazolone compound

The present application relates to solid state forms of a triazolone compound which exhibit mPGES-1 enzyme inhibition activity, specifically N-(4-chloro-3-(5-oxo-1-(4-(trifluoromethyl)phenyl)-4,5-dihydro-1H-1,2,4-triazol-3-yl)benzyl) pivalamide (Compound of formula II), and process for preparation thereof. 

Provided is an improved process for the preparation of arformoterol L-(+)-tartrate, and more specifically provided is a novel process for the preparation of arformoterol L-(+)-tartrate via arformoterol D-(&#x2212;)-tartrate.

Process for the preparation of arformoterol or salt thereof

The present disclosure is directed to salts of N-{4-[2,4-difluoro-3-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl}dimethyl-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-5-yl)acetamide and process for the preparation thereof (formula II). 

Amides of 2-amino-4-arylthiazole compounds and their salts

A process for preparation of 1-isobutyl-1H-imidazo-[4,5-c]-quinoline-5-N-oxide, comprising oxidation of 1-isobutyl-1H-imidazoquinoline with meta-chloroperbenzoic acid.

Process for preparation of 4-amino-1-isobutyl-1H-imidazo[4,5-C]-quinoline (Imiquimod)

Growing community of inventors

Thane, India

Sachin Baban Gavhane